144 related articles for article (PubMed ID: 36058827)
1. NOR-1 (NR4A3) immunostaining on cytologic preparations for the preoperative diagnosis of acinic cell carcinoma of the salivary gland.
Krishnan V; Nguyen L; Shen R; Lieu D; De Peralta-Venturina M; Fan X
J Am Soc Cytopathol; 2022; 11(6):352-358. PubMed ID: 36058827
[TBL] [Abstract][Full Text] [Related]
2. NOR-1 distinguishes acinic cell carcinoma from its mimics on fine-needle aspiration biopsy specimens.
Nguyen L; Chopra S; Laskar DB; Rao J; Lieu D; Chung F; Kim ED; de Peralta-Venturina M; Bose S; Balzer B
Hum Pathol; 2020 Aug; 102():1-6. PubMed ID: 32416209
[TBL] [Abstract][Full Text] [Related]
3. Utility of NR4A3 on FNA cytology smears and liquid-based preparations of salivary gland.
Millan N; Tjendra Y; Zuo Y; Jorda M; Garcia-Buitrago M; Velez-Torres JM; Gomez-Fernandez C
Cancer Cytopathol; 2022 Dec; 130(12):949-954. PubMed ID: 35913415
[TBL] [Abstract][Full Text] [Related]
4. NR4A3 Immunostain Is a Highly Sensitive and Specific Marker for Acinic Cell Carcinoma in Cytologic and Surgical Specimens.
Viswanathan K; Beg S; He B; Zhang T; Cantley R; Lubin DJ; Shi Q; Maleki Z; Asiry S; Rao R; Katabi N; Nakaguro M; Faquin WC; Sadow PM; Siddiqui MT; Scognamiglio T
Am J Clin Pathol; 2022 Jan; 157(1):98-108. PubMed ID: 34508546
[TBL] [Abstract][Full Text] [Related]
5. A minority of cases of acinic cell carcinoma of the salivary glands are driven by an NR4A2 rearrangement: the diagnostic utility of the assessment of NR4A2 and NR4A3 alterations in salivary gland tumors.
Klubíčková N; Grossmann P; Šteiner P; Baněčková M; Mosaieby E; Koshyk O; Michal M; Leivo I; Skálová A
Virchows Arch; 2023 Feb; 482(2):339-345. PubMed ID: 36469101
[TBL] [Abstract][Full Text] [Related]
6. Utility of an immunocytochemical analysis for pan-Trk in the cytodiagnosis of secretory carcinoma of the salivary gland.
Ito H; Ishida M; Ebisu Y; Okano K; Sandoh K; Noda Y; Miyasaka C; Fujisawa T; Yagi M; Iwai H; Tsuta K
Diagn Cytopathol; 2021 Aug; 49(8):E329-E335. PubMed ID: 33885200
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of NR4A3 immunohistochemistry (IHC) and fluorescence in situ hybridization and comparison with DOG1 IHC for FNA diagnosis of acinic cell carcinoma.
Skaugen JM; Seethala RR; Chiosea SI; Landau MS
Cancer Cytopathol; 2021 Feb; 129(2):104-113. PubMed ID: 32809265
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of acinic cell carcinoma of the salivary gland on cytology specimens: Role of NOR-1 (NR4A3) immunohistochemistry.
Meiklejohn K; Hrones M; Wang M; Prasad ML; Cai G; Adeniran A; Gilani SM
Cytopathology; 2023 May; 34(3):219-224. PubMed ID: 36825365
[TBL] [Abstract][Full Text] [Related]
9. NR4A3 Immunohistochemistry Reliably Discriminates Acinic Cell Carcinoma from Mimics.
Wong KS; Mariño-Enriquez A; Hornick JL; Jo VY
Head Neck Pathol; 2021 Jun; 15(2):425-432. PubMed ID: 32910350
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic role of fine needle aspiration cytology (FNAC) in the evaluation of salivary gland swelling: an institutional experience.
Naz S; Hashmi AA; Khurshid A; Faridi N; Edhi MM; Kamal A; Khan M
BMC Res Notes; 2015 Mar; 8():101. PubMed ID: 25879702
[TBL] [Abstract][Full Text] [Related]
11. Nuclear NR4A3 Immunostaining Is a Specific and Sensitive Novel Marker for Acinic Cell Carcinoma of the Salivary Glands.
Haller F; Skálová A; Ihrler S; Märkl B; Bieg M; Moskalev EA; Erber R; Blank S; Winkelmann C; Hebele S; Baněčková M; Wiemann S; Müller S; Zenk J; Eils R; Iro H; Hartmann A; Agaimy A
Am J Surg Pathol; 2019 Sep; 43(9):1264-1272. PubMed ID: 31094928
[TBL] [Abstract][Full Text] [Related]
12. Cytologic diagnosis of acinic-cell carcinoma of salivary glands.
Nagel H; Laskawi R; Büter JJ; Schröder M; Chilla R; Droese M
Diagn Cytopathol; 1997 May; 16(5):402-12. PubMed ID: 9143841
[TBL] [Abstract][Full Text] [Related]
13. Acinic-cell carcinoma, papillary-cystic variant: a diagnostic dilemma in salivary gland aspiration.
Ali SZ
Diagn Cytopathol; 2002 Oct; 27(4):244-50. PubMed ID: 12357504
[TBL] [Abstract][Full Text] [Related]
14. NR4A3 fluorescence in situ hybridization analysis in cytologic and surgical specimens of acinic cell carcinoma.
Shi Q; Zhang B; Bsirini C; Li L; Giampoli EJ; Magliocca KR; Reid M; Zhou Z
Hum Pathol; 2022 Sep; 127():86-91. PubMed ID: 35700750
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization for ETV6 gene rearrangements on destained cytological smears: Role in diagnosis of secretory carcinoma of salivary gland.
Mahendru R; Sarma C; Kakkar A; Kumar R; Kaur K; Thakar A
Cancer Cytopathol; 2023 Jul; 131(7):442-453. PubMed ID: 36973972
[TBL] [Abstract][Full Text] [Related]
16. [Expression of NR4A3/NOR-1 in acinic cell carcinoma of the salivary gland].
Cheng K; Wang X; Wei X; Ma J; Xia QY; Shi QL; Zhou XJ; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2020 Nov; 49(11):1142-1146. PubMed ID: 33152819
[No Abstract] [Full Text] [Related]
17. Nodular oncocytic hyperplasia: Can cytomorphology allow for the preoperative diagnosis of a nonneoplastic salivary disease?
Rooper LM; Onenerk M; Siddiqui MT; Faquin WC; Bishop JA; Ali SZ
Cancer Cytopathol; 2017 Aug; 125(8):627-634. PubMed ID: 28411376
[TBL] [Abstract][Full Text] [Related]
18. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands.
Haller F; Bieg M; Will R; Körner C; Weichenhan D; Bott A; Ishaque N; Lutsik P; Moskalev EA; Mueller SK; Bähr M; Woerner A; Kaiser B; Scherl C; Haderlein M; Kleinheinz K; Fietkau R; Iro H; Eils R; Hartmann A; Plass C; Wiemann S; Agaimy A
Nat Commun; 2019 Jan; 10(1):368. PubMed ID: 30664630
[TBL] [Abstract][Full Text] [Related]
19. Acinic cell carcinoma of the salivary gland associated with lymphoid-rich stroma. A diagnostic dilemma on cytology: Study of two cases.
Mir F; Rohra P; Aakash N; Furlan K; Cheng L; Ghai R; Reddy V; Gattuso P
Diagn Cytopathol; 2021 Feb; 49(2):E55-E59. PubMed ID: 32761994
[TBL] [Abstract][Full Text] [Related]
20. NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift.
Richardson ET; Selenica P; Pareja F; Cin PD; Hanlon E; Weigelt B; Reis-Filho JS; Hornick JL; Jo VY; Schnitt SJ
Mod Pathol; 2023 Jun; 36(6):100144. PubMed ID: 36828363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
